Exciting opportunity to potentially design new antibody therapy with Absci and AstraZeneca collaboration
An AI-designed antibody against an oncology target can now be delivered following a collaboration between Absci Corporation and AstraZeneca.
Archives for December 4, 2023
Pfizer axes new weight loss pill after patients experience serious side effects
Pfizer is discontinuing danuglipron, its twice-daily weight loss pill, after more than half of patients in a clinical trial stopped taking it.